Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Sales (2024 - 2025)

Kura Oncology (KURA) has disclosed Return on Sales for 2 consecutive years, with 4.67% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 4735.0% to 4.67% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.38%, a 11360.0% decrease, with the full-year FY2025 number at 4.13%, down 90.0% from a year prior.
  • Return on Sales was 4.67% for Q4 2025 at Kura Oncology, down from 3.57% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 162.85% in Q2 2025 to a low of 4.67% in Q4 2025.